Status:
NOT_YET_RECRUITING
PhotobiomoduLation for pAtientS With Advanced hEart failuRe
Lead Sponsor:
Semmelweis University Heart and Vascular Center
Collaborating Sponsors:
Laser Light Medical Innovations Ltd.
Conditions:
Heart Failure With Reduced Ejection Fraction
Heart Failure, Systolic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to examine the effectiveness of photobiomodulation therapy in patients with advanced-stage heart failure with reduced ejection fraction (HFrEF), who have been referred bu...
Eligibility Criteria
Inclusion
- Advanced-stage HFrEF patients who were ineligible for heart transplantation Patients over 18 years of age The expected lifespan exceeds 1 year Consent form
Exclusion
- Non-compliant patient Pregnant women Drug or alcohol abuse The patient is participating in another clinical trial
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06501313
Start Date
August 1 2024
End Date
May 1 2026
Last Update
July 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.